Principal Investigator, Professor: Epigenetic regulation in infection and immunity :

Na Yang
Address:NO.1 West Beichen Road, Chaoyang District, Beijing 100101, China
Telephone/fax:
E-mail:yangna@im.ac.cn
Research Interests
Dr. Yang’s research expertise is on structural bases of epigenetic regulation of biological processes, including histone modifications and DNA methylation, as well as nucleic acid-protein interactions. Current focus of Dr. Yang’s group is on the study of molecular mechanisms of epigenetic regulation in infection and immunity. By studying the interaction and interference between pathogenic proteins and host epigenetic factors, they aim to reveal pathogenic mechanisms of various microbes. Drug target validation and structure-based drug design will be carried out to facilitate the development of effective therapeutics for prevention and treatment of pathogenic infections. 

The lab principally uses structure-based approaches to reveal the relationship between macromolecular structures and their functions. Virtual screening (CADD and AIDD) and rational drug design based on the solved structures will also be used. Finally, candidate compounds will be evaluated and optimized by iterative Structure-Activity Relationship (SAR) analyses. 

Their specific research directions include: 
1.Epigenetic mechanisms governing gene expression involved in microbe-host interactions. 2.Mechanisms by which pathogenic proteins influence higher-order structures of host chromatin. 3.Roles of epigenetic factors during T cell development, and chemical intervention of T cell exhaustion by targeting epigenetic factors.
Education/degrees
B.S 2000, Biophysics, School of Life Sciences, Peking University 
Ph.D 2005, Biochemistry & Molecular biology, Institute of Biophysics, Chinese Academy of Sciences (CAS)
Work experience
Professional Appointments 
2006.04-2008.09, Postdoc, Shenzhen Graduate School, Peking University 
2008.10-2013.11, Associate Investigator, Institute of Biophysics, CAS 
2013.12-2017.04, Investigator, Institute of Biophysics, CAS 
2015.10-2017.04, Professor, College of Life Sciences, University of the Chinese Academy of Sciences 
2017.04-2024.11, Professor, College of Pharmacy, Nankai University 
2024.11-present, Principle Investigator, Institute of Microbiology, CAS 
Professional Services 
2021-present, Vice president, Molecular Biophysics Section of the Chinese Biophysical Society 
2015-2021, Secretary General, Molecular Biophysics Section of the Chinese Biophysical Society 
2019-present, Board member, Epigenetics Section of the Genetics Society of China 
2016-2021, Board member, Chinese Crystallographic society 
2015-2019, Member, Youth Federation of the Chinese Academy of Sciences 
2014-2023, Consultant, Commission on Biological Macromolecules, International Union of Crystallography (IUCr) 
2018-2019, Young scientist of World Economic Forum
Awards and Honors
2019 15th Science and Technology Award for Youth, Tianjin 
2019 Bring in leading Innovative Talent of Tianjin City 
2018 Science and Technology Award of Beijing Municipality, Second prize 
2017 Distinguished Young Scholars of Tianjin City 
2016 National Excellent Young Scientists 
2015 Excellent Member of the Youth Innovation Promotion Association of CAS 
2011 Lu Jiaxi Young Talent Award of Chinese Academy of Sciences 
2011 Member of the Youth Innovation Promotion Association of CAS 
2006 First prize of Chinese Post Doctor Award 
2005 President prize of Chinese Academy of Sciences 
2004 First prize of Director Scholarship of Institute of Biophysics, CAS 
2001 Scholarship of Excellent Graduate Student in the graduate school of CAS
The main research areas
Mechanism of the allosteric activation of epigenetic modification enzyme and rational drug design
Publication
1. Shi, F.D.#, Zhang, K.#, Cheng, Q.X., Che, S.Y., Zhi, S.X., Yu, Z.Y., Liu, F., Duan, F.F., Wang, Y.M.* and Yang, N.* (2024) Molecular mechanism governing RNA-binding property of mammalian TRIM71 protein. Science Bulletin, Vol. 69, 72–81.
2. Yang, J.#, Dan, J.M.#, Zhao, N.N., Liu, L.L., Wang, H.S., Liu, Q.Q., Wang, L.L., Li, J., Wu, Y.W., Chen, F.L., Fu, W.L., Liu, F., Lin, M.Q., Zhang, W.Y., Chen, F.Q., Liu, X.Q., Lv, X.Y., Chen, Q., Wu, X.D., Niu, Y.Y.*, Yang, N.*, Zhu, Y.S.*, Long, J.F.*, Liu, L.* (2024) Zscan4 mediates ubiquitination and degradation of co-repressor complex to promote chromatin accessibility in 2C-like cells. Proc. Natl. Acad. Sci. USA, in press.
3. Liu, F., Wang, J.*, Xu, R.M.* and Yang, N.* (2023) Energy landscape quantifications of histone H3.3 recognition by chaperon DAXX reveal an uncoupled binding specificity and affinity. Physical Chemistry Chemical Physics, Vol. 25, 27981–27993.
4. Liu, C.P.#, Yu, Z.#, Xiong, J.#, Hu, J.#, Song, A.#, Ding, D., Yu, C., Yang, N., Wang, M., Yu, J., Hou, P., Zeng, K., Li, Z., Zhang, Z., Zhang, X., Li, W., Zhang, Z., Zhu, B.*, Li, G.* and Xu, R.M.* (2023) Structural insights into histone binding and nucleosome assembly by chromatin assembly factor-1. Science, Vol. 381, eadd8673.
5. Liu, F.#, Pang, N.N.#, Xu, R.M. and Yang, N.* (2023) Mechanism and design of allosteric activators of SIRT1. Protein & Cell, Vol. 14, 387-392.
6. Sun, J.X., Liu, F., Yuan, L.X., Pang, N.N., Zhu, B. and Yang, N.* (2023) Mechanism studies of the activation of DNA methyltransferase DNMT1 triggered by histone H3 ubiquitination, revealed by multi-scale molecular dynamics simulations. Science China Life Sciences, Vol. 66, 313-323.
7. Pang, N.N.#, Sun, J.X.#, Che, S.Y. and Yang, N.* (2022) Structural study of fungus-specific histone deacetylase Hos3 and insight into developing selective inhibitors with antifungal activity. Journal of Biological Chemistry, Vol. 298, 102068.
8. Ma, S.#, Zhang, J.Y.#, Guo, Q.S., Cao, C., Bao, K.W., Liu, L., Chen, D.G., Liu, Z., Yang, J., Yang, N.*, Yao, Z.* and Shi, L.* (2022) Disrupting PHF8-TOPBP1 connection elicits a breast tumor-specific vulnerability to chemotherapeutics. Cancer Letters, Vol. 530, 29-44.
9. Ma, S.#, Cao, C.#, Che, S.Y.#, Wang, Y.J.#, Su, D.X.#, et al., Yao, Z.*, Yang, N.* and Shi, L.* (2021) PHF8-promoted TOPBP1 demethylation drives ATR activation and preserves genome stability. Science Advances, Vol. 7, eabf7684.
10. Xu, X.#, Wang, M.Z.#, Sun, J.X.#, Yu, Z.Y.#, Li, G.H., Yang, N.* and Xu, R.M.* (2021) Structure specific DNA recognition by the SLX1-SLX4 endonuclease complex. Nucleic Acid Research, Vol. 49, 7740-7752.
11. Sun, J.X.#, Li, Z.B#. and Yang, N.* (2021) Mechanism of the conformational change of the protein methyltransferase SMYD3: a molecular dynamics simulation study. International Journal of Molecular Sciences, Vol. 22, 7185 (1-21).
12. Liu, F. and Yang, N.* (2020) Multiscale landscape of molecular mechanism of SIRT1 activation by STACs. Physical Chemistry Chemical Physics, Vol. 22, 826-837.
13. Song, X.S.#, Yang, L.L.#, Wang, M.Z., Gu, Y., Ye, B.Q., Fan, Z.S., Xu, R.M.* and Yang, N.* (2019) A higher-order configuration of the heterodimeric DOT1L-AF10 coiled-coil domains potentiates their leukemogenenic activity. Proc. Natl. Acad. Sci. USA, Vol. 116, 19917-19923.
14. Sun, J.X., Shi, F.D. and Yang, N.* (2019) Exploration of the substrate preference of lysine methyltransferase SMYD3 by molecular dynamics simulations. ACS Omega, Vol. 4, 19573-19581.
15. Li, Y.#, Duan, F.F.#, Zhao, Y.T., Gu, K.L., Liao, L.Q., Su, H.B., Hao, J., Zhang, K., Yang, N. and Wang Y.M.* (2019) A TRIM71 binding long noncoding RNA Trincr1 represses FGF/ERK signaling in embryonic stem cells. Nature Communications, Vol. 10, 1368.
16. Zhang, L.#, Serra-Cardona, A.#, Zhou, H., Wang, N., Yang, N., Zhang, Z.* and Xu, R.M.* (2018) Multisite substrate recognition in Asf1-dependent acetylation of histone H3 K56 by Rtt109. Cell, Vol. 174, 818-830.
17. Fu, W.Q.#, Liu, N.#, Qiao, Q.#, Wang, M., Min, J.R., Zhu, B.*, Xu, R.M.* and Yang, N.* (2016) Structural Basis for Substrate Preference of SMYD3, A SET Domain-containing Protein Lysine Methyltransferase. Journal of Biological Chemistry, Vol. 291, 9173-9180.
18. Fang, D.#, Gan, H.#, Lee, J.H.#, Han, J.#, Wang, Z.#, Riester, S.M., Jin, L., Chen, J., Zhou, H., Wang, J., Zhang, H., Yang, N., Bradley, E.W., Ho, T.H., Rubin, B.P., Bridge, J.A., Thibodeau, S.N., Ordog, T., Chen, Y., van Wijnen, A.J., Oliveira, A.M., Xu, R.M., Westendorf, J.J. and Zhang, Z.* (2016) The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas. Science, Vol. 29, 1316-1325.
19. Cao, D.F., Wang, M., Qiu, X.Y., Liu, D.X., Jiang, H.L., Yang, N.* and Xu, R.M.* (2015) Structural basis for allosteric, substrate-dependent stimulation of SIRT1 activity by resveratrol. Genes & Development, Vol. 29, 1316-1325.
20. Yang, D.X.#, Fang, Q.L.#, Wang, M.#, Ren, R., Wang, H., He, M., Sun, Y.W., Yang, N.* and Xu, R.M.* (2013) Nα-acetylated Sir3 stabilizes the conformation of a nucleosome-binding loop in the BAH domain. Nature Structural & Molecular Biology, Vol. 20, 1116-1118.